COVID-19 dengan Komorbid Tuberkulosis Paru dan Diabetes Melitus | Zendy

Muthia Faurin | Zendy; Fauzar Fauzar | Zendy; Roza Kurniati | Zendy; Alexander Kam | Zendy; Eva Decroli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19 dengan Komorbid Tuberkulosis Paru dan Diabetes Melitus

Author(s) -

Muthia Faurin,

Fauzar Fauzar,

Roza Kurniati,

Alexander Kam,

Eva Decroli

Publication year - 2021

Publication title -

jurnal ilmu kesehatan indonesia

Language(s) - English

Resource type - Journals

ISSN - 2722-4848

DOI - 10.25077/jikesi.v1i3.466

Subject(s) - medicine , diabetes mellitus , pulmonary tuberculosis , covid-19 , tuberculosis , pharmacotherapy , intensive care medicine , pediatrics , disease , pathology , infectious disease (medical specialty) , endocrinology

A 61-year-old man was admitted a confirmed COVID-19 with comorbid pulmonary tuberculosis and type 2 diabetes mellitus. The patient was given favipiravir therapy, category 1 of antituberculosis drug, and insulin therapy. The patient responded well to therapy with improved clinical and laboratory indicators. Key words: COVID-19, pulmonary tuberculosis, diabetes mellitus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research